Companhia De Bebidas Das Americas Ambev Stock Hits New 52-Week High (ABV)
Companhia de Bebidas das Americas Ambev (NYSE:ABV) hit a new 52-week high Thursday as it is currently trading at $44.72, above its previous 52-week high of $44.63 with 308,610 shares traded as of 10:21 a.m. ET. Average volume has been 1.8 million shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Companhia de Bebidas das Americas Ambev (NYSE: ABV) hit a new 52-week high Thursday as it is currently trading at $44.72, above its previous 52-week high of $44.63 with 308,610 shares traded as of 10:21 a.m. ET. Average volume has been 1.8 million shares over the past 30 days. Companhia de Bebidas das Americas Ambev has a market cap of $136.61 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 4% year to date as of the close of trading on Wednesday. Companhia de Bebidas das Americas Ambev engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt, and other non-alcoholic and non-carbonated products in the Americas. It also sells bottled water, isotonics, and ready-to-drink teas. The company has a P/E ratio of 103.6, above the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Companhia de Bebidas das Americas Ambev as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Companhia de Bebidas das Americas Ambev Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.